162 related articles for article (PubMed ID: 10822221)
1. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication.
Gunton JE; Stiel J; Clifton-Bligh P; Wilmshurst E; McElduff A
Eur J Endocrinol; 2000 Jun; 142(6):587. PubMed ID: 10822221
[TBL] [Abstract][Full Text] [Related]
2. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment.
D'Cruz D; Chesser AM; Lightowler C; Comer M; Hurst MJ; Baker LR; Raine AE
Br J Rheumatol; 1995 Nov; 34(11):1090-1. PubMed ID: 8542214
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
[TBL] [Abstract][Full Text] [Related]
5. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
6. Carbimazole induced ANCA positive vasculitis.
Pandey S; Kushwaha RS; Mehndiratta P; Mehndiratta MM
J Assoc Physicians India; 2008 Oct; 56():801-3. PubMed ID: 19263707
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease.
Miller RM; Savige J; Nassis L; Cominos BI
Australas J Dermatol; 1998 May; 39(2):96-9. PubMed ID: 9611379
[TBL] [Abstract][Full Text] [Related]
12. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
[TBL] [Abstract][Full Text] [Related]
14. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K
Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036
[TBL] [Abstract][Full Text] [Related]
15. Propylthiouracil-induced ANCA-positive erythema nodosum treated with thalidomide.
Wan P; Zhao X; Hunasehally RY; Shi R; Zheng J
Int J Dermatol; 2012 Mar; 51(3):345-8. PubMed ID: 22348574
[TBL] [Abstract][Full Text] [Related]
16. [Anti-endothelial cell antibodies(AECA) are associated with disease activity of propylthiouracil induced antineutrophil cytoplasmic antibody (ANCA) positive vasculitis].
Yu F; Zhao MH; Zhang Y; Zhang YK
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):374-7. PubMed ID: 16086055
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
18. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
19. Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature.
Morita S; Ueda Y; Eguchi K
Endocr J; 2000 Aug; 47(4):467-70. PubMed ID: 11075728
[TBL] [Abstract][Full Text] [Related]
20. Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity.
Yu F; Zhao MH; Zhang YK; Zhang Y; Wang HY
Clin Exp Immunol; 2005 Mar; 139(3):569-74. PubMed ID: 15730404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
